267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford
Jul 20, 2023
35:26
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.
The Readout Loud